Skip to content

EV / sales at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
5.1×-0.9×
Danaher logo
DanaherDHR
-0.8×
Agilent Technologies logo
Agilent TechnologiesA
4.8×-0.2×
Illumina logo
IlluminaILMN
4.5×+1.4×
TEC
Bio-TechneTECH
6.8×-1.1×
Revvity logo
RevvityRVTY
4.4×-0.9×

Other financials

Income statement

See full
Revenue$110.7M+19.3%
Gross profit$57.1M+24.1%
Operating income-$45.9M-10.4%
Net income-$44.0M-11.9%
EPS (diluted)-$0.71-7.6%

Balance sheet

See full
Cash & equivalents$124.9M-41.4%
Total debt$110.8M+16.3%
Total equity$455.1M+3.4%
Total assets$676.2M+13.5%

Cash flow

See full
Operating cash flow-$17.6M-35.2%
CapEx$7.9M+90.3%
Free cash flow-$25.4M-48.5%

Valuation

See full
Market cap$5.45B+24.4%
Enterprise value$5.44B+30.4%
P/S13.3×+0.7×

Profitability

See full
Gross margin52.1%+5.4pp
Operating margin-33.9%-9.9pp
Net margin-19.8%-7.7pp
FCF margin-23.2%+7.0pp

Returns & leverage

See full
Return on equity-18.2%-6.3pp
Debt / equity0.2×0.0×
Current ratio2.7×-1.8×

Where this comes from

Calculated from Twist Bioscience Corporation’s reported figures.

Based on the most recent quarter.

The official record: Twist Bioscience Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Twist Bioscience Corporation's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Twist Bioscience Corporation's EV / sales?
Twist Bioscience Corporation (TWST) reported EV / sales of 7.1× in Q1 2026.
How has Twist Bioscience Corporation's EV / sales changed year-over-year?
Twist Bioscience Corporation's EV / sales increased by 10.7% year-over-year, from 6.4× to 7.1×.
What is the long-term trend for Twist Bioscience Corporation's EV / sales?
Over 5 years (2020 to 2025), Twist Bioscience Corporation's EV / sales has grown at a -36.5% compound annual growth rate (CAGR), from 41.2× to 4.3×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.